Business Context and Reporting Period
This Form 8-K is filed by NanoVibronix, Inc. (trading symbol: NAOV) on August 5, 2020. The registrant is an emerging growth company incorporated in Delaware. The filing addresses two primary events: a notice of potential delisting from the Nasdaq Capital Market and the unregistered sale of equity securities.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin figures. However, it discloses the following financial status indicators:
- Stockholders' Equity: The company has failed to meet the Nasdaq minimum requirement of $2.5 million in stockholders' equity in each of its last three periodic reports.
- Debt and Liquidity: No specific debt or liquidity metrics are disclosed in this text.
Material Changes and Events
Delisting Notice (Item 3.01)
Nasdaq notified the company that its common shares are subject to delisting on August 14, 2020, due to non-compliance with the minimum stockholders' equity requirement (Listing Rule 5550(b)(1)). The company intends to submit a Hearing Request by August 12, 2020, which will automatically stay the delisting action pending a decision by the Nasdaq Hearings Panel.
Unregistered Sale of Equity (Item 3.02)
On August 5, 2020, the company issued an additional 375,000 shares of common stock to Bespoke Growth Partners, Inc. under a consulting agreement dated February 11, 2019. This issuance was made in reliance on exemptions under Section 4(a)(2) of the Securities Act and Rule 506 of Regulation D.
Outlook, Risks, and Management Commentary
Management plans to present an update on its compliance plan to the Nasdaq Hearings Panel and may request an additional extension of up to 180 calendar days to regain compliance. The filing highlights significant risks associated with potential delisting, including:
- Difficulty in buying or selling the company's common stock.
- Reduced availability of accurate quotations.
- A material decline in the stock price.
- Impaired ability to raise capital.
There is no assurance that the compliance plan will be accepted or that the company will regain compliance.
Investor Verification Checklist
- Verify the status of the Hearing Request submission by the August 12, 2020 deadline.
- Review the company's most recent periodic reports (10-K/10-Q) to confirm the exact stockholders' equity balance.
- Monitor for the outcome of the Nasdaq Hearings Panel decision regarding the extension request.
- Assess the impact of the 375,000 share issuance on existing shareholder dilution.